Homepage Galen

Galen is a recognised Speciality Pharmaceutical Company marketing products throughout the UK, Ireland, Europe and the US.

OVERVIEW

This site galen-pharma.com currently has an average traffic ranking of zero (the lower the more traffic). We have scanned sixteen pages within the site galen-pharma.com and found four websites linking to galen-pharma.com. There are two contacts and addresses for galen-pharma.com to help you communicate with them. This site galen-pharma.com has been on the internet for six hundred and sixty-three weeks, eighteen days, three hours, and fifteen minutes.
Pages Crawled
16
Links to this site
4
Contacts
2
Locations
2
Online Since
Jan 2012

GALEN-PHARMA.COM RANKINGS

This site galen-pharma.com has seen varying quantities of traffic all over the year.
Traffic for galen-pharma.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for galen-pharma.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for galen-pharma.com

Date Range

All time
This Year
Last Year
Last Month

GALEN-PHARMA.COM HISTORY

This site galen-pharma.com was created on January 23, 2012. It was updated on the date of January 23, 2012. This domain will expire on January 23, 2017. As of today, it is six hundred and sixty-three weeks, eighteen days, three hours, and fifteen minutes young.
REGISTERED
January
2012
UPDATED
January
2012
EXPIRED
January
2017

LENGTH OF LIFE

12
YEARS
8
MONTHS
17
DAYS

LINKS TO WEB SITE

Irish American Business Chamber Network IABCN

Become an IABCN member today. Networking opportunities include both in person events and online via our Members Only Linked In group, Facebook and Twitter pages.

The Galen Trustsaver collection of cost-saving medicines

This website is intended for healthcare professionals only. If you are a patient looking for information click here. If you would like to find out more about Galen, its products and information on the disease areas we cover, please visit www.

BioQ Pharma

BioQ Pharma to Present at the 15th Annual Needham Healthcare Conference. BioQ Pharma to Present at the JMP Securities Life Sciences Conference. BioQ Pharma Enters into Strategic Partnership with Galen Limited. We are a specialty pharmaceutical company focused on setting a new standard of care for infusible drugs. We intend to set a new standard of care in the presentation and administration of infusible pharmaceuticals.

WHAT DOES GALEN-PHARMA.COM LOOK LIKE?

Desktop Screenshot of galen-pharma.com Mobile Screenshot of galen-pharma.com Tablet Screenshot of galen-pharma.com

CONTACTS

Almac Group Ltd

9 Charlestown Road

Craigavon, County Armagh, BT63 5PW

UK

Almac Group Ltd

Almac Group Ltd

9 Charlestown Road

Craigavon, County Armagh, BT63 5PW

UK

GALEN-PHARMA.COM HOST

We detected that a single page on galen-pharma.com took one thousand eight hundred and thirty-one milliseconds to load. We observed a SSL certificate, so therefore we consider this site secure.
Load time
1.831 secs
SSL
SECURE
Internet Protocol
5.39.40.91

NAME SERVERS

dns1.almac-sciences.com
dns3.almac-sciences.com

BROWSER ICON

SERVER OS

I detected that this website is using the Apache server.

PAGE TITLE

Homepage Galen

DESCRIPTION

Galen is a recognised Speciality Pharmaceutical Company marketing products throughout the UK, Ireland, Europe and the US.

CONTENT

This site galen-pharma.com has the following on the web site, "EU Enquiries 44 0 28 3833 4974." We noticed that the website also said " At Galen, we strive to deliver innovation, quality and value to Healthcare Professionals and their Patients." It also stated " Content intended for the US. Our products are available in a number of countries worldwide. We are focused on a diverse range of treatment areas. Contact a member of our team or request further information." The header had Galen as the highest ranking keyword. It was followed by InterGal, Sir Allen McClay, and Human Health which isn't as ranked as highly as Galen. The next words the site used was Branded Products. Generic Products was also included but might not be viewed by search crawlers.

SEEK MORE WEBSITES

galenrasputins Journal

Most recent journal entries recorded in galen rasputin. Tuesday, June 29th, 2010. By Ron Rosenbaum is a Grand Master Troll. He pretends to be an agnostic, but then goes onto attack atheism and subtly reveals that he is not an agnostic, but a theist almost certainly of the Christian verity. It is masterfully done and something all of us trolls should aspire to. Sunday, June 20th, 2010.

Leading experts in developing and evaluating disease-specific patient reported outcome measures Galen Research

Galen Research - the Science of Measurement. Development of clinician-reported outcome measures. Developing new language versions of patient-reported outcome measures. Qualitative interviews, burden of illness studies, utility assessments. Literature reviews and evaluation of PROs.

Pastor Galens Sabbatical

You are invited to share in my journey as I enter a time of Sabbath Rest. Walk with me as I journey with God and share in what I am experiencing. Wednesday, September 1, 2010. Today it is one year that I began the three month sabbatical that lasted till the end of November. Wow! A year has passed already. Of course, that presentation was made eight months ago, and only one month after I had returned from the sabbatical. What does my perspective look like now? Sunday, November 15, 2009.

Galen-Wolfe Marc - DeviantArt

Forgot Password or Username? Deviant for 7 Years. This is the place where you can personalize your profile! By moving, adding and personalizing widgets.

Galen Partners

Experienced healthcare investors focused on growth equity. Healthcare stands on the precipice of massive change. We believe the healthcare system will undergo a greater transformation during the next 10 years than has been experienced over the last 50 years. Healthcare historically lacked transparency, was less attuned to costs, and focused more on volume than outcomes. Replacing that model will be companies that truly create value within the healthcare system. Our focus is on healthcare growth equity.